Kufril-D Syrup is a combination pharmaceutical formulation containing Phenylephrine (5mg/5ml), Chlorpheniramine Maleate (2mg/5ml), and Dextromethorphan Hydrobromide (15mg/5ml), designed for the symptomatic relief of upper respiratory tract conditions. Phenylephrine acts as a selective alpha-1 adrenergic receptor agonist, providing effective nasal decongestion by vasoconstriction of nasal mucosal blood vessels. Chlorpheniramine Maleate, a first-generation antihistamine, alleviates allergic symptoms such as rhinorrhea, sneezing, and itching by competitively inhibiting histamine H1 receptors. Dextromethorphan Hydrobromide serves as a centrally acting antitussive agent, suppressing the cough reflex through its action on the medullary cough center without causing significant sedation. Kufril-D Syrup is indicated for the management of common cold, allergic rhinitis, sinusitis, and cough associated with upper respiratory tract infections. The syrup formulation facilitates ease of administration, particularly in pediatric and adult patients unable to swallow tablets. Caution is advised in patients with hypertension, glaucoma, or those taking monoamine oxidase inhibitors. Adverse effects may include dizziness, drowsiness, dry mouth, and gastrointestinal disturbances. It is recommended to use Kufril-D Syrup under medical supervision, adhering to prescribed dosages to ensure safety and efficacy.